Stratec Biomedical AG STRATEC BIOMEDICAL ORD SHS
Stratec Biomedical AG STRATEC BIO.../ DE000STRA555 /
0RAR
15/11/2024 17:00:12
|
Var.
+0.60
|
Volume |
Denaro- |
Lettera- |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
29.50EUR
|
+2.08%
|
58 Fatturato: 1,726.15 |
-Quantità in denaro: - |
-Quantità in lettera: - |
353.74 mill.EUR |
1.89% |
27.20 |
Descrizione business
STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Marcus Wolfinger |
Consiglio di amministrazione |
Dr. Claus Vielsack, Dr. Robert Siegle, Dr. Georg Bauer |
Consiglio di sorveglianza |
Prof. Dr. Georg Heni, Dr. Frank Hiller, Dr. Rolf Vornhagen, Dr. Patricia Geller |
Dati aziendali
Name: |
STRATEC SE |
Indirizzo: |
Gewerbestraße 37,D-75217 Birkenfeld |
Telefono: |
+49-7082-7916-0 |
Fax: |
+49-7082-7916-999 |
E-mail: |
info@stratec.com
|
Internet: |
www.stratec.com |
Industria: |
Healthcare |
Settore: |
Medical Products |
Sub settore: |
Advanced Medical Devices |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
35.57% |
Data dell'IPO: |
25/08/1998 |
Rapporti con gli investitori
Name: |
Jan Keppeler |
IR telefono: |
+49-7082-7916-991 |
IR Fax: |
+49-7082-7916-9190 |
IR e-mail: |
ir@stratec.com
|